F5F8D2
MCID: FCT034
MIFTS: 42

Factor V and Factor Viii, Combined Deficiency of, 2 (F5F8D2)

Categories: Blood diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Factor V and Factor Viii, Combined Deficiency of, 2

MalaCards integrated aliases for Factor V and Factor Viii, Combined Deficiency of, 2:

Name: Factor V and Factor Viii, Combined Deficiency of, 2 57 29 6 71
Factor V and Factor Viii, Combined Deficiency of 57 13 71
F5f8d2 57 73
F5f8d 58 54
Deficiency, Combined, Factor V and Factor Viii, Type 2 39
Combined Deficiency of Factor V and Factor Viii 58
Factor V and Factor Viii Combined Deficiency 2 73
Multiple Coagulation Factor Deficiency 2 73
Fv and Fviii Combined Deficiency 58
Mcfd2 73

Characteristics:

Orphanet epidemiological data:

58
combined deficiency of factor v and factor viii
Inheritance: Autosomal recessive; Prevalence: 1-9/1000000 (Europe); Age of onset: All ages; Age of death: any age;

HPO:

31
factor v and factor viii, combined deficiency of, 2:
Inheritance autosomal recessive inheritance


Classifications:

Orphanet: 58  
Rare haematological diseases


External Ids:

OMIM® 57 613625
MeSH 44 D025861
ICD10 via Orphanet 33 D68.8
UMLS via Orphanet 72 C1856883
Orphanet 58 ORPHA35909
MedGen 41 C3150889
UMLS 71 C1856883 C3150889

Summaries for Factor V and Factor Viii, Combined Deficiency of, 2

OMIM® : 57 Combined deficiency of factor V (612309) and factor VIII (300841) is characterized by bleeding symptoms similar to those in hemophilia (306700) or parahemophilia (227400), caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma FV and FVIII antigen and activity levels are in the range of 5 to 30%. Inheritance of F5F8D is autosomal recessive and distinct from the coinheritance of FV deficiency and FVIII deficiency (summary by Zhang and Ginsburg, 2004). (613625) (Updated 05-Mar-2021)

MalaCards based summary : Factor V and Factor Viii, Combined Deficiency of, 2, also known as factor v and factor viii, combined deficiency of, is related to factor v and factor viii, combined deficiency of, 1 and prothrombin deficiency. An important gene associated with Factor V and Factor Viii, Combined Deficiency of, 2 is MCFD2 (Multiple Coagulation Factor Deficiency 2, ER Cargo Receptor Complex Subunit), and among its related pathways/superpathways are Metabolism of proteins and Vesicle-mediated transport. Affiliated tissues include liver, and related phenotypes are prolonged prothrombin time and reduced factor viii activity

UniProtKB/Swiss-Prot : 73 Factor V and factor VIII combined deficiency 2: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal.

Related Diseases for Factor V and Factor Viii, Combined Deficiency of, 2

Diseases related to Factor V and Factor Viii, Combined Deficiency of, 2 via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
# Related Disease Score Top Affiliating Genes
1 factor v and factor viii, combined deficiency of, 1 32.5 MCFD2 LMAN1
2 prothrombin deficiency 31.0 MCFD2 F8
3 hemarthrosis 31.0 MCFD2 F8
4 thrombocytopenia 30.7 MCFD2 F8 F5
5 factor xiii deficiency 30.6 MCFD2 F8 F5
6 hemorrhagic disease 30.6 MCFD2 F8 F5
7 brachydactyly, type d 30.5 MCFD2 LMAN1 F8
8 factor v deficiency 30.1 MCFD2 LMAN1 F8 F5
9 factor viii deficiency 29.5 MCFD2 LMAN1 F8 F5
10 factor v and factor viii, combined deficiency of, with normal protein c and protein c inhibitor 11.6
11 coumarin resistance 10.9
12 venezuelan hemorrhagic fever 10.9
13 good syndrome 10.9
14 hemophilia a 10.5
15 hemophilia 10.5
16 rare hemorrhagic disorder 10.4
17 epidermodysplasia verruciformis 1 10.2
18 von willebrand's disease 10.2
19 ichthyosis 10.2
20 placental abruption 10.2
21 ichthyosis, acquired 10.2
22 autosomal recessive disease 10.1
23 acquired hemophilia 9.8 F8 F5
24 acquired hemophilia a 9.8 F8 F5
25 sagittal sinus thrombosis 9.8 F8 F5
26 thrombosis 9.8 F8 F5
27 post-thrombotic syndrome 9.8 F8 F5
28 sneddon syndrome 9.8 F8 F5
29 intracranial thrombosis 9.8 F8 F5
30 carotid artery occlusion 9.8 F8 F5
31 thrombophlebitis 9.8 F8 F5
32 central retinal vein occlusion 9.8 F8 F5
33 thrombophilia due to activated protein c resistance 9.8 F8 F5
34 thrombophilia 9.8 F8 F5
35 pulmonary artery disease 9.8 F8 F5
36 retinal artery occlusion 9.8 F8 F5
37 factor xi deficiency 9.7 F8 F5
38 vein disease 9.7 F8 F5
39 thrombophilia due to thrombin defect 9.7 F8 F5
40 pulmonary embolism 9.7 F8 F5
41 homocystinuria 9.6 F8 F5
42 blood coagulation disease 9.6 F8 F5
43 cerebrovascular disease 9.5 F8 F5

Graphical network of the top 20 diseases related to Factor V and Factor Viii, Combined Deficiency of, 2:



Diseases related to Factor V and Factor Viii, Combined Deficiency of, 2

Symptoms & Phenotypes for Factor V and Factor Viii, Combined Deficiency of, 2

Human phenotypes related to Factor V and Factor Viii, Combined Deficiency of, 2:

58 31 (show all 19)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 prolonged prothrombin time 58 31 hallmark (90%) Very frequent (99-80%) HP:0008151
2 reduced factor viii activity 58 31 hallmark (90%) Very frequent (99-80%) HP:0003125
3 prolonged partial thromboplastin time 58 31 hallmark (90%) Very frequent (99-80%) HP:0003645
4 reduced coagulation factor v activity 58 31 hallmark (90%) Very frequent (99-80%) HP:0003225
5 epistaxis 58 31 frequent (33%) Frequent (79-30%) HP:0000421
6 gingival bleeding 58 31 frequent (33%) Frequent (79-30%) HP:0000225
7 bruising susceptibility 58 31 frequent (33%) Frequent (79-30%) HP:0000978
8 bleeding with minor or no trauma 58 31 frequent (33%) Frequent (79-30%) HP:0011889
9 prolonged bleeding after dental extraction 58 31 frequent (33%) Frequent (79-30%) HP:0006298
10 prolonged bleeding following circumcision 58 31 frequent (33%) Frequent (79-30%) HP:0030137
11 hematuria 58 31 occasional (7.5%) Occasional (29-5%) HP:0000790
12 gastrointestinal hemorrhage 58 31 occasional (7.5%) Occasional (29-5%) HP:0002239
13 intracranial hemorrhage 58 31 occasional (7.5%) Occasional (29-5%) HP:0002170
14 menorrhagia 58 31 occasional (7.5%) Occasional (29-5%) HP:0000132
15 joint hemorrhage 58 31 occasional (7.5%) Occasional (29-5%) HP:0005261
16 prolonged bleeding after surgery 58 31 occasional (7.5%) Occasional (29-5%) HP:0004846
17 hyperuricemia 58 31 very rare (1%) Very rare (<4-1%) HP:0002149
18 hyperlipidemia 58 31 very rare (1%) Very rare (<4-1%) HP:0003077
19 persistent bleeding after trauma 31 HP:0001934

Clinical features from OMIM®:

613625 (Updated 05-Mar-2021)

Drugs & Therapeutics for Factor V and Factor Viii, Combined Deficiency of, 2

Search Clinical Trials , NIH Clinical Center for Factor V and Factor Viii, Combined Deficiency of, 2

Genetic Tests for Factor V and Factor Viii, Combined Deficiency of, 2

Genetic tests related to Factor V and Factor Viii, Combined Deficiency of, 2:

# Genetic test Affiliating Genes
1 Factor V and Factor Viii, Combined Deficiency of, 2 29 MCFD2

Anatomical Context for Factor V and Factor Viii, Combined Deficiency of, 2

MalaCards organs/tissues related to Factor V and Factor Viii, Combined Deficiency of, 2:

40
Liver

Publications for Factor V and Factor Viii, Combined Deficiency of, 2

Articles related to Factor V and Factor Viii, Combined Deficiency of, 2:

(show all 46)
# Title Authors PMID Year
1
Genotype-phenotype correlation in combined deficiency of factor V and factor VIII. 57 6 61 54
18391077 2008
2
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. 61 6 54 57
12717434 2003
3
Combined deficiency of factor V and factor VIII is due to mutations in either LMAN1 or MCFD2. 61 57 54
16304051 2006
4
Familial multiple coagulation factor deficiencies: new biologic insight from rare genetic bleeding disorders. 61 54 57
15333032 2004
5
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. 6
9546392 1998
6
Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. 6
9045860 1997
7
[Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers]. 6
13229969 1954
8
Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency. 61 54
20142513 2010
9
Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex provides insight into combined deficiency of factor V and factor VIII. 61 54
20138881 2010
10
[Combined deficiency of factors V and VIII caused by a novel compound heterozygous mutation of gene Lman1]. 61 54
20137144 2010
11
EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII. 54 61
20007547 2010
12
A novel missense mutation causing abnormal LMAN1 in a Japanese patient with combined deficiency of factor V and factor VIII. 61 54
19787799 2009
13
A review of ERGIC-53: its structure, functions, regulation and relations with diseases. 54 61
19609866 2009
14
Combined Factor V and Factor VIII Deficiency. 61 54
19598067 2009
15
Recent developments in the understanding of the combined deficiency of FV and FVIII. 61 54
19183188 2009
16
Combined FV and FVIII deficiency. 54 61
19141160 2008
17
The first case of combined coagulation factor V and coagulation factor VIII deficiency in Poland due to a novel p.Tyr135Asn missense mutation in the MCFD2 gene. 61 54
18685427 2008
18
New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2. 54 61
18590741 2008
19
Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. 54 61
17971482 2008
20
The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. 54 61
18056485 2008
21
Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene. 61 54
17910641 2007
22
Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India. 61 54
17610559 2007
23
A new case of combined factor V and factor VIII deficiency further suggests that the LMAN1 M1T mutation is a frequent cause in Italian patients. 61 54
17287640 2007
24
Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient. 54 61
16676083 2006
25
Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII. 54 61
16044454 2005
26
Combined factor V and factor VIII deficiency in a Thai patient: a case report of genotype and phenotype characteristics. 54 61
15876275 2005
27
Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency. 61 54
10090934 1999
28
The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. 61 54
9245995 1997
29
Altered phenotype in LMAN1-deficient mice with low levels of residual LMAN1 expression. 61
33196840 2020
30
Low factor V level ameliorates bleeding diathesis in patients with combined deficiency of factor V and factor VIII. 61
31558466 2019
31
[Congenital factor V and factor VIII deficiency discovered in an elderly patient with abnormal bleeding after trauma]. 61
29743396 2018
32
Congenital factor V and VIII deficiency in women: a systematic review of literature and report of two new cases. 61
26376169 2016
33
Congenital combined deficiency of coagulation factors: a study of seven patients. 61
25215615 2015
34
Combined FV and FVIII deficiency (F5F8D) in a Chinese family with a novel missense mutation in MCFD2 gene. 61
25354775 2014
35
Successful Pregnancy in a Patient with Combined Deficiency of Factor V and Factor VIII. 61
24883216 2014
36
Combined deficiency of coagulation factors V and VIII: an update. 61
23852824 2013
37
Multiple coagulation factor deficiency protein 2 contains the ability to support stem cell self-renewal. 61
23660967 2013
38
Successful percutaneous coronary intervention in a patient with combined deficiency of FV and FVIII due to novel compound heterozygous mutations in LMAN1. 61
23557496 2013
39
Structural characterization of carbohydrate binding by LMAN1 protein provides new insight into the endoplasmic reticulum export of factors V (FV) and VIII (FVIII). 61
23709226 2013
40
The COPII pathway and hematologic disease. 61
22586181 2012
41
Unveiling the unfolding pathway of F5F8D disorder-associated D81H/V100D mutant of MCFD2 via multiple molecular dynamics simulations. 61
22208273 2012
42
Analysis of newly detected mutations in the MCFD2 gene giving rise to combined deficiency of coagulation factors V and VIII. 61
21492322 2011
43
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin. 61
21795745 2011
44
Two new mutations at ERGIC-53 gene in a Turkish family. 61
20460353 2011
45
Inherited and acquired factor V deficiency. 61
21245750 2011
46
Molecular analysis in two Tunisian families with combined factor V and factor VIII deficiency. 61
20491958 2010

Variations for Factor V and Factor Viii, Combined Deficiency of, 2

ClinVar genetic disease variations for Factor V and Factor Viii, Combined Deficiency of, 2:

6 (show top 50) (show all 224)
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 MCFD2 NM_001171506.2(MCFD2):c.149+5G>A SNV Pathogenic 2865 rs387906286 2:47136157-47136157 2:46909018-46909018
2 MCFD2 NM_001171506.2(MCFD2):c.309+1G>A SNV Pathogenic 2866 rs387906287 2:47134948-47134948 2:46907809-46907809
3 MCFD2 NM_001171506.2(MCFD2):c.103del (p.Gln35fs) Deletion Pathogenic 2867 rs1253799389 2:47136208-47136208 2:46909069-46909069
4 MCFD2 NM_001171506.2(MCFD2):c.249del (p.Asp83fs) Deletion Pathogenic 2868 rs1294221028 2:47135009-47135009 2:46907870-46907870
5 MCFD2 NM_001171506.2(MCFD2):c.265_272del (p.Asp89fs) Deletion Pathogenic 2869 rs1558461545 2:47134986-47134993 2:46907847-46907854
6 MCFD2 NM_001171506.2(MCFD2):c.387C>G (p.Asp129Glu) SNV Pathogenic 2870 rs137852913 2:47132656-47132656 2:46905517-46905517
7 MCFD2 NM_001171506.2(MCFD2):c.407T>C (p.Ile136Thr) SNV Pathogenic 2871 rs137852914 2:47132636-47132636 2:46905497-46905497
8 MCFD2 NM_001171506.2(MCFD2):c.241G>T (p.Asp81Tyr) SNV Pathogenic 2872 rs78289603 2:47135017-47135017 2:46907878-46907878
9 LMAN1 NM_005570.4(LMAN1):c.89dup (p.Asp31fs) Duplication Pathogenic 8062 rs869312030 18:57026387-57026388 18:59359155-59359156
10 LMAN1 NM_005570.4(LMAN1):c.1149+2T>C SNV Pathogenic 8063 rs869312031 18:57005990-57005990 18:59338758-59338758
11 LMAN1 NM_005570.4(LMAN1):c.796del (p.Gln266fs) Deletion Pathogenic 8064 rs869312032 18:57014771-57014771 18:59347539-59347539
12 LMAN1 NM_005570.4(LMAN1):c.1356del (p.Asn452_Leu453insTer) Deletion Pathogenic 8065 rs869312033 18:57000341-57000341 18:59333109-59333109
13 LMAN1 NM_005570.4(LMAN1):c.2T>C (p.Met1Thr) SNV Pathogenic 8066 rs121909253 18:57026475-57026475 18:59359243-59359243
14 MCFD2 NM_001171506.2(MCFD2):c.375_376GA[4] (p.Asp127fs) Microsatellite Likely pathogenic 627205 rs1484184249 2:47132662-47132663 2:46905523-46905524
15 MCFD2 NM_001171506.2(MCFD2):c.149+5G>A SNV Likely pathogenic 2865 rs387906286 2:47136157-47136157 2:46909018-46909018
16 LMAN1 NM_005570.4(LMAN1):c.904A>T (p.Lys302Ter) SNV Likely pathogenic 627401 rs183873209 18:57013202-57013202 18:59345970-59345970
17 LMAN1 NM_005570.4(LMAN1):c.1178T>C (p.Val393Ala) SNV Uncertain significance 800356 rs374176132 18:57005831-57005831 18:59338599-59338599
18 LMAN1 NM_005570.4(LMAN1):c.-5C>T SNV Uncertain significance 327581 rs765835101 18:57026481-57026481 18:59359249-59359249
19 LMAN1 NM_005570.4(LMAN1):c.*794A>G SNV Uncertain significance 891479 18:56997531-56997531 18:59330299-59330299
20 LMAN1 NM_005570.4(LMAN1):c.*763T>A SNV Uncertain significance 891480 18:56997562-56997562 18:59330330-59330330
21 LMAN1 NM_005570.4(LMAN1):c.775G>A (p.Val259Ile) SNV Uncertain significance 891546 18:57014792-57014792 18:59347560-59347560
22 LMAN1 NM_005570.4(LMAN1):c.*2359A>G SNV Uncertain significance 891655 18:56995966-56995966 18:59328734-59328734
23 LMAN1 NM_005570.4(LMAN1):c.*1390T>C SNV Uncertain significance 889924 18:56996935-56996935 18:59329703-59329703
24 LMAN1 NM_005570.4(LMAN1):c.*1300C>T SNV Uncertain significance 889925 18:56997025-56997025 18:59329793-59329793
25 LMAN1 NM_005570.4(LMAN1):c.1434G>A (p.Thr478=) SNV Uncertain significance 889984 18:56998712-56998712 18:59331480-59331480
26 LMAN1 NM_005570.4(LMAN1):c.1412C>T (p.Pro471Leu) SNV Uncertain significance 889985 18:56998734-56998734 18:59331502-59331502
27 LMAN1 NM_005570.4(LMAN1):c.1411C>T (p.Pro471Ser) SNV Uncertain significance 889986 18:56998735-56998735 18:59331503-59331503
28 LMAN1 NM_005570.4(LMAN1):c.1391C>G (p.Pro464Arg) SNV Uncertain significance 889987 18:56998755-56998755 18:59331523-59331523
29 LMAN1 NM_005570.4(LMAN1):c.1310T>C (p.Ile437Thr) SNV Uncertain significance 889988 18:57000387-57000387 18:59333155-59333155
30 LMAN1 NM_005570.4(LMAN1):c.*2670G>C SNV Uncertain significance 891408 18:56995655-56995655 18:59328423-59328423
31 LMAN1 NM_005570.4(LMAN1):c.*2637T>C SNV Uncertain significance 891409 18:56995688-56995688 18:59328456-59328456
32 LMAN1 NM_005570.4(LMAN1):c.*2541T>C SNV Uncertain significance 891410 18:56995784-56995784 18:59328552-59328552
33 LMAN1 NM_005570.4(LMAN1):c.*1271A>G SNV Uncertain significance 891476 18:56997054-56997054 18:59329822-59329822
34 LMAN1 NM_005570.4(LMAN1):c.*1164A>G SNV Uncertain significance 891477 18:56997161-56997161 18:59329929-59329929
35 LMAN1 NM_005570.4(LMAN1):c.846G>A (p.Ser282=) SNV Uncertain significance 327572 rs377676111 18:57013260-57013260 18:59346028-59346028
36 LMAN1 NM_005570.4(LMAN1):c.*2650G>A SNV Uncertain significance 327542 rs886054030 18:56995675-56995675 18:59328443-59328443
37 LMAN1 NM_005570.4(LMAN1):c.*939C>T SNV Uncertain significance 327562 rs149781610 18:56997386-56997386 18:59330154-59330154
38 LMAN1 NM_005570.4(LMAN1):c.1392G>A (p.Pro464=) SNV Uncertain significance 327568 rs149932943 18:56998754-56998754 18:59331522-59331522
39 LMAN1 NM_005570.4(LMAN1):c.*1862A>G SNV Uncertain significance 889247 18:56996463-56996463 18:59329231-59329231
40 LMAN1 NM_005570.4(LMAN1):c.*1631A>G SNV Uncertain significance 889248 18:56996694-56996694 18:59329462-59329462
41 LMAN1 NM_005570.4(LMAN1):c.*319A>G SNV Uncertain significance 889302 18:56998006-56998006 18:59330774-59330774
42 LMAN1 NM_005570.4(LMAN1):c.*210G>A SNV Uncertain significance 889303 18:56998115-56998115 18:59330883-59330883
43 LMAN1 NM_005570.4(LMAN1):c.*185A>T SNV Uncertain significance 889304 18:56998140-56998140 18:59330908-59330908
44 LMAN1 NM_005570.4(LMAN1):c.*21T>G SNV Uncertain significance 889305 18:56998304-56998304 18:59331072-59331072
45 LMAN1 NM_005570.4(LMAN1):c.1527C>A (p.Phe509Leu) SNV Uncertain significance 889306 18:56998331-56998331 18:59331099-59331099
46 LMAN1 NM_005570.4(LMAN1):c.169C>G (p.Leu57Val) SNV Uncertain significance 889361 18:57026308-57026308 18:59359076-59359076
47 LMAN1 NM_005570.4(LMAN1):c.106G>C (p.Asp36His) SNV Uncertain significance 889362 18:57026371-57026371 18:59359139-59359139
48 LMAN1 NM_005570.4(LMAN1):c.*1556C>G SNV Uncertain significance 889922 18:56996769-56996769 18:59329537-59329537
49 LMAN1 NM_005570.4(LMAN1):c.*2099C>T SNV Uncertain significance 891657 18:56996226-56996226 18:59328994-59328994
50 LMAN1 NM_005570.4(LMAN1):c.*2021A>C SNV Uncertain significance 891658 18:56996304-56996304 18:59329072-59329072

UniProtKB/Swiss-Prot genetic disease variations for Factor V and Factor Viii, Combined Deficiency of, 2:

73
# Symbol AA change Variation ID SNP ID
1 MCFD2 p.Asp129Glu VAR_019076 rs137852913
2 MCFD2 p.Ile136Thr VAR_019077 rs137852914
3 MCFD2 p.Asp81His VAR_072245 rs78289603
4 MCFD2 p.Tyr135Asn VAR_072246 rs748641905

Expression for Factor V and Factor Viii, Combined Deficiency of, 2

Search GEO for disease gene expression data for Factor V and Factor Viii, Combined Deficiency of, 2.

Pathways for Factor V and Factor Viii, Combined Deficiency of, 2

GO Terms for Factor V and Factor Viii, Combined Deficiency of, 2

Cellular components related to Factor V and Factor Viii, Combined Deficiency of, 2 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 Golgi membrane GO:0000139 9.46 MCFD2 LMAN1 F8 F5
2 endoplasmic reticulum-Golgi intermediate compartment GO:0005793 9.37 MCFD2 LMAN1
3 platelet alpha granule lumen GO:0031093 9.32 F8 F5
4 ER to Golgi transport vesicle membrane GO:0012507 9.26 MCFD2 LMAN1
5 COPII-coated ER to Golgi transport vesicle GO:0030134 9.13 LMAN1 F8 F5
6 endoplasmic reticulum-Golgi intermediate compartment membrane GO:0033116 8.92 MCFD2 LMAN1 F8 F5

Biological processes related to Factor V and Factor Viii, Combined Deficiency of, 2 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 platelet degranulation GO:0002576 9.37 F8 F5
2 blood coagulation GO:0007596 9.33 LMAN1 F8 F5
3 hemostasis GO:0007599 9.32 F8 F5
4 protein N-linked glycosylation via asparagine GO:0018279 9.26 MCFD2 LMAN1
5 ER to Golgi vesicle-mediated transport GO:0006888 9.26 MCFD2 LMAN1 F8 F5
6 COPII vesicle coating GO:0048208 8.92 MCFD2 LMAN1 F8 F5

Molecular functions related to Factor V and Factor Viii, Combined Deficiency of, 2 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 metal ion binding GO:0046872 9.26 MCFD2 LMAN1 F8 F5
2 copper ion binding GO:0005507 8.62 F8 F5

Sources for Factor V and Factor Viii, Combined Deficiency of, 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....